The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail

Rupafin 10mg tablets

J. Uriach y Compania S.A. PA1129/001/001

Main Information

Trade NameRupafin 10mg tablets
Active SubstancesRupatadine (as fumarate)
Dosage FormTablet
Licence HolderJ. Uriach y Compania S.A.
Licence NumberPA1129/001/001

Group Information

ATC CodeR06AX Other antihistamines for systemic use
R06AX28 rupatadine


License statusAuthorised
Licence Issued09/01/2004
Legal statusProduct subject to prescription which may be renewed (B)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusMarketed


Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available
« Back